Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma.
Elisa GelliDebora SonciniPamela BecheriniClaudia MartinuzziKatia TodoertiAntonia CagnettaSara AquinoFabio GuoloMaurizio MiglinoSantina BruzzoneAlessio NencioniAntonino NeriRoberto Massimo LemoliMichele CeaPublished in: Blood advances (2023)